| Literature DB >> 32059811 |
Elke Warmerdam1, Jeffrey M Hausdorff2, Arash Atrsaei3, Yuhan Zhou4, Anat Mirelman5, Kamiar Aminian3, Alberto J Espay6, Clint Hansen7, Luc J W Evers8, Andreas Keller9, Claudine Lamoth4, Andrea Pilotto10, Lynn Rochester11, Gerhard Schmidt12, Bastiaan R Bloem8, Walter Maetzler7.
Abstract
Mobile health technologies (wearable, portable, body-fixed sensors, or domestic-integrated devices) that quantify mobility in unsupervised, daily living environments are emerging as complementary clinical assessments. Data collected in these ecologically valid, patient-relevant settings can overcome limitations of conventional clinical assessments, as they capture fluctuating and rare events. These data could support clinical decision making and could also serve as outcomes in clinical trials. However, studies that directly compared assessments made in unsupervised and supervised (eg, in the laboratory or hospital) settings point to large disparities, even in the same parameters of mobility. These differences appear to be affected by psychological, physiological, cognitive, environmental, and technical factors, and by the types of mobilities and diagnoses assessed. To facilitate the successful adaptation of the unsupervised assessment of mobility into clinical practice and clinical trials, clinicians and researchers should consider these disparities and the multiple factors that contribute to them.Entities:
Year: 2020 PMID: 32059811 DOI: 10.1016/S1474-4422(19)30397-7
Source DB: PubMed Journal: Lancet Neurol ISSN: 1474-4422 Impact factor: 44.182